Rabia Ozden
Technik-/Wissenschafts-/F&E-Leiter bei OCULAR THERAPEUTIX, INC.
Vermögen: 642 827 $ am 30.04.2024
Ursprung des Netzwerks ersten Grades von Rabia Ozden
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 26 | |
| Public Company | Pharmaceuticals: Major | 23 | |
| Subsidiary | Pharmaceuticals: Major | 15 | |
| Subsidiary | Pharmaceuticals: Generic | 9 | |
6
| Subsidiary | Biotechnology | 6 |
Quark Pharmaceuticals, Inc.
 Quark Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Quark Pharmaceuticals, Inc. discovers and develops novel RNAi-based therapeutics. The firm’s products include QPI-1002 and QPI-1007 is being developed as a neuroprotective agent for the treatment of optic neuropathies that result in the death of retinal ganglion cells. The company was founded by Daniel Zurr, David M. Fineman and J. Gregory Swendsen in December 1993 and is headquartered in Fremont, CA.
3
| Subsidiary | Pharmaceuticals: Major | 3 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Rabia Ozden
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
NightstaRx Ltd.
 NightstaRx Ltd. Medical/Nursing ServicesHealth Services NightstaRx Ltd. develops and commercializes therapies for retinal dystrophies. It offers retinal gene therapy that provides one-time cure for choroideremia (a rare inherited cause of blindness) and other retinal dystrophies. The company was founded by Robert MacLaren, Miguel Seabra, and Matthew During in January 2014 and is headquartered in London, the United Kingdom. | Medical/Nursing Services | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
| ALLERGAN, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| IVERIC BIO, INC. | Pharmaceuticals: Generic | Chairman Director of Finance/CFO Chief Executive Officer Chief Tech/Sci/R&D Officer President | |
| BIOGEN INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Compliance Officer Corporate Officer/Principal Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel Corporate Officer/Principal Corporate Officer/Principal | |
American Academy of Ophthalmology, Inc.
 American Academy of Ophthalmology, Inc. Miscellaneous Commercial ServicesCommercial Services American Academy of Ophthalmology, Inc. is the world's largest association of eye physicians and surgeons. The non-profit company is based in San Francisco, CA, and has subsidiaries in the United States. The company advocates for patients and the public and set standards for ophthalmic education. The organization provides information about managing a practice, clinical pearls, and how to thrive in residency for young ophthalmologists. The company also offers an Outstanding Humanitarian Service Award and have committees that are essential to the establishment and implementation of the organization's mission and strategic goals. The Academy's website, EyeSmart, provides information on eye diseases, treatments, news, and tips for lifelong eye health. The company also has a faculty development program for their annual meeting and offer a program called Eyecelerator that advances eye care innovation by connecting creative entrepreneurs with mission-driven investors and access to markets. | Miscellaneous Commercial Services | Corporate Officer/Principal Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
| Harvard Business School | College/University | Corporate Officer/Principal Masters Business Admin Masters Business Admin Masters Business Admin | |
| University of Michigan | College/University | Doctorate Degree Doctorate Degree Undergraduate Degree | |
| San Jose State University | College/University | Undergraduate Degree Graduate Degree Graduate Degree | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Director/Board Member Director/Board Member Human Resources Officer | |
| PTC THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Northeastern University
 Northeastern University Other Consumer ServicesConsumer Services Founded in 1898, Northeastern University is a private research university located in the heart of Boston. Northeastern teaches worldwide experiential learning, urban engagement, and interdisciplinary research that meets global and societal needs. The University offers a range of undergraduate and graduate programs leading to degrees through the doctorate in nine colleges and schools. | College/University | Undergraduate Degree Graduate Degree Graduate Degree | |
Convergence Pharmaceuticals Ltd.
 Convergence Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Convergence Pharmaceuticals Ltd. develops novel analgesics for the treatment of chronic pain. It provides CNV1014802, a small molecule state-dependent sodium channel blocker; and CNV1061436, a sodium channel blocker for the treatment of central nervous system disorders, including epilepsy and bipolar disorder. The company was founded by Brenda Reynolds in September 2010 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| SANGAMO THERAPEUTICS, INC. | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
SV Health Investors LLC
 SV Health Investors LLC Investment ManagersFinance SV Health Investors LLC is a Venture Capital firm, a subsidiary of SV Health Investors LLP founded in 2006. SV Health Investors LLC is headquartered in Boston. | Investment Managers | Private Equity Investor Private Equity Investor Corporate Officer/Principal | |
| University of California, Los Angeles | College/University | Graduate Degree Undergraduate Degree Undergraduate Degree | |
| The Trustees of Columbia University in The City of New York | College/University | Masters Business Admin Graduate Degree Undergraduate Degree | |
| TERNS PHARMACEUTICALS, INC. | Biotechnology | Chairman Chief Executive Officer Chief Operating Officer | |
Danube Pharmaceuticals, Inc.
 Danube Pharmaceuticals, Inc. BiotechnologyHealth Technology Danube Pharmaceuticals, Inc. provides bio pharmaceutical services. It engages in the discovery and development of therapies and devices for ophthalmology. The firm's products include DNB-001, a small molecule for the treatment of glaucoma. The company was founded in 2006 and is headquartered in New York, NY. | Biotechnology | Chairman Chief Tech/Sci/R&D Officer | |
| OXURION NV | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| GYROSCOPE THERAPEUTICS HOLDINGS PLC | Biotechnology | Director/Board Member Chairman | |
University of Minnesota
 University of Minnesota Other Consumer ServicesConsumer Services Digi-Key Corp. distributes electronic components. It also distributes semiconductors, discrete, electromechanical parts. Its products include audio products, batteries, cable assemblies, capacitors, computer & video accessories, connectors, crystals & oscillators, discrete semiconductor products and many more. The company was founded by Ronald A. Stordahl in 1972 and is headquartered in Thief River Falls, MN. | College/University | Corporate Officer/Principal Doctorate Degree | |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses | College/University | Undergraduate Degree Undergraduate Degree | |
| Kellogg School of Management | College/University | Masters Business Admin Masters Business Admin | |
| HARROW, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| American Society of Cataract & Refractive Surgery Foundation | Director/Board Member Chairman | ||
WaveTec Vision Systems, Inc.
 WaveTec Vision Systems, Inc. Electronic ComponentsElectronic Technology WaveTec Vision Systems, Inc. develops and provides wavefront measurement technologies. It focuses on research, development, manufacturing, and distribution of the Optiwave Refractive Analysis (ORA) system with VerifEye used during cataract surgery. The firm offers ophthalmic medical devices. The company was founded by Kenneth C. Aldrich, William B. Adams, Thomas J. Berryman, and Tony Van Heugten in 1997 and is headquartered in Aliso Viejo, CA. | Electronic Components | Director/Board Member Director/Board Member | |
Surface Ophthalmics, Inc.
 Surface Ophthalmics, Inc. BiotechnologyHealth Technology Surface Ophthalmics, Inc. operates as a biopharmaceutical company. It focuses on development and commercialization of innovative therapeutics. The firm’s current drug pipeline consists of three proprietary drug candidates. Surface topical eye drop drug candidates, SURF-100 and SURF-200, utilize a patented delivery vehicle. The company is founded by Mark L. Baum and it is headquartered in San Diego, CA. | Biotechnology | Director/Board Member Founder | |
TherOptix, Inc.
 TherOptix, Inc. Electronic ComponentsElectronic Technology TherOptix, Inc. develops and manufactures drug-eluting contact lens. The company is headquartered in San Francisco, CA. | Electronic Components | Director/Board Member Director/Board Member | |
| AEGERION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
NEA Management Co. LLC
 NEA Management Co. LLC Investment ManagersFinance New Enterprise Associates LLC (New Enterprise Associates) is a venture capital firm founded in 1977. The firm headquartered in Menlo Park, California. | Investment Managers | Private Equity Investor Corporate Officer/Principal | |
| AURA BIOSCIENCES, INC. | Biotechnology | Chief Operating Officer Director/Board Member | |
Aurion Biotech, Inc.
 Aurion Biotech, Inc. Medical/Nursing ServicesHealth Services Aurion Biotech, Inc. is a clinical-stage biotech company with offices in multiple locations. Aurion Biotech has initiated clinical trials in the US in 2023. The company is based in Seattle, WA. The company's mission is to restore vision to millions of patients with life-changing regenerative therapies. Aurion Biotech has received the prestigious Prix Galien award for best start-up in biotech. The company's first candidate is an off-the-shelf, clinically validated cell therapy for corneal care, which has received regulatory approval. The company is privately held and backed by leading investors, including Deerfield, Alcon, Petrichor, Flying L Partners, Falcon Vision/KKR, and Visionary Ventures. Greg Kunst has been the CEO of the company since 2021. | Medical/Nursing Services | Director/Board Member President | |
Encore Vision, Inc.
 Encore Vision, Inc. Medical/Nursing ServicesHealth Services Encore Vision, Inc. operates as an ophthalmology clinic. It offers EV06, an ophthalmic pharmaceutical solution in a conventional eye drop bottle, which includes its proprietary active pharmaceutical ingredient (API). The company is headquartered in Spokane, WA. | Medical/Nursing Services | Director/Board Member Director/Board Member | |
Aerpio Therapeutics, Inc.
 Aerpio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aerpio Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company focused on advancing innovative therapies for vascular diseases. The firm develops small molecules and monoclonal antibodies for the treatment of vascular disease and enhancement of wound healing. Its two lead programs include a tie-2 activator for diabetic macular edema and vascular leak, and a hypoxia-inducible factor 1-a stabilizer for wound healing and the treatment of inflammatory bowel disease. The company was founded by Joseph H. Gardner and Robert Shalwitz in 2011 and is headquartered in Cincinnati, OH. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
AcuFocus, Inc.
 AcuFocus, Inc. Medical SpecialtiesHealth Technology AcuFocus, Inc. develops KAMRA inlay for the treatment of presbyopia. Its KAMRA inlay is an intra-corneal inlay designed to create a small aperture effect, allowing the eye to see near and intermediate objects more clearly. The company was founded in 2001 and is headquartered in Irvine, CA. | Medical Specialties | Director/Board Member Director/Board Member | |
| The American Society of Cataract & Refractive Surgery | Director/Board Member President | ||
Alcon Laboratories, Inc.
 Alcon Laboratories, Inc. Medical SpecialtiesHealth Technology Alcon Laboratories, Inc. develops and manufactures ophthalmic pharmaceutical products. The firm offers over-the-counter eye care products, medical devices, equipment, ophthalmic drugs, surgical instruments, needles, and sutures for microsurgery and disposable drapes. The company was founded by Robert Alexander and William Conner in 1945 and is headquartered in Fort Worth, TX. | Medical Specialties | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Gyroscope Therapeutics Ltd.
 Gyroscope Therapeutics Ltd. BiotechnologyHealth Technology Gyroscope Therapeutics Ltd. operates as an ophthalmology firm. It develops a cutting edge, genetically-defined therapies for the treatment of eye diseases linked to an unbalanced complement system. The company was founded on April 18, 2016 and is headquartered in Stevenage, the United Kingdom. | Biotechnology | Director/Board Member Chairman | |
Entasis Therapeutics, Inc.
 Entasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Entasis Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovey, development, and commercialization of novel antibacterial prodcuts to treat serious infections caused by multi-drug resistant Gram-negative bacteria. Its pipeline includes ETX2514SUL, targeting Acinetobacter baumannii infections; ETX0282CPDP, targeting Enterobacteriaceae infections; a Non-Beta-lactam PBP inhibitor, targeting Gram-negative infections; and zoliflodacin, targeting Neisseria gonorrhoeae. The company was founded by Manoussos Perros in May 2015 and is headquartered in Waltham, MA. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| University of Cambridge | College/University | Doctorate Degree Graduate Degree | |
| INTERCEPT PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel | |
| Tufts University | College/University | Undergraduate Degree Undergraduate Degree | |
| TEARLAB CORPORATION | Medical Specialties | Director/Board Member Director/Board Member | |
| The Retina Society | Corporate Officer/Principal Director/Board Member | ||
| VERTEX PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | President Corporate Officer/Principal | |
Bowdoin College
 Bowdoin College Other Consumer ServicesConsumer Services Bowdoin College is an independent, nonsectarian, coeducational residential, undergraduate liberal arts institution founded in 1794. It is located in Brunswick, ME. | College/University | Undergraduate Degree Graduate Degree | |
| University of California, Berkeley | College/University | Undergraduate Degree Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 45 |
| Vereinigtes Königreich | 6 |
| Belgien | 2 |
Sektoral
| Health Technology | 27 |
| Consumer Services | 14 |
| Health Services | 4 |
| Finance | 3 |
| Electronic Technology | 3 |
Operativ
| Director/Board Member | 473 |
| Corporate Officer/Principal | 174 |
| Independent Dir/Board Member | 153 |
| Undergraduate Degree | 68 |
| Chief Tech/Sci/R&D Officer | 64 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Richard Lindstrom | 50 |
| David Mott | 45 |
| Adrienne Graves | 38 |
| Arnold Lewis Oronsky | 35 |
| Heather Elizabeth Preston | 34 |
| Reed Tuckson | 31 |
| Clarence Machado | 30 |
| Bruce Peacock | 28 |
| Vicki Sato | 28 |
| David Guyer | 27 |
| Jim Scopa | 26 |
| Anne VanLent | 23 |
| Charles M. Warden | 23 |
| C. Nicholson | 22 |
| Laurent Fischer | 22 |
- Börse
- Insiders
- Rabia Ozden
- Unternehmensverbindungen
